These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease. Löllgen H, Just H, Wollschläger H, Kersting F. Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729 [Abstract] [Full Text] [Related]
13. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing. Verdouw PD, Saxena PR, Schamhardt HC, van der Hoek TM, Rutteman AM. Eur J Pharmacol; 1980 Jun 27; 64(4):209-20. PubMed ID: 7389819 [Abstract] [Full Text] [Related]
14. Alinidine antagonizes the myocardial effects of adenosine. Lang U, Streller I, Walland A. Eur J Pharmacol; 1989 May 02; 164(1):13-22. PubMed ID: 2753076 [Abstract] [Full Text] [Related]
15. Comparative study of cardiovascular effects of clonidine and alinidine in cross-perfused dog atrial preparations. Chiba S, Ogiwara Y, Furukawa Y, Akahane K. Jpn Heart J; 1989 Nov 02; 30(6):895-902. PubMed ID: 2632839 [Abstract] [Full Text] [Related]
17. Improvement of perfusion and function of ischaemic porcine myocardium after reduction of heart rate by alinidine. Schamhardt HC, Verdouw PD, Saxena PR. J Cardiovasc Pharmacol; 1981 Nov 02; 3(4):728-38. PubMed ID: 6167803 [Abstract] [Full Text] [Related]
18. Cardiovascular effects of N-allyl clonidine (ST 567, alinidine): a substance with specific bradycardiac action during neuroleptanesthesia in humans. Fitzal S, Zimpfer M. Int J Clin Pharmacol Ther Toxicol; 1982 Sep 02; 20(9):404-7. PubMed ID: 7141760 [Abstract] [Full Text] [Related]